Lexicon Pharmaceuticals, Inc. (LXRX)
2.325
+0.02
(+1.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Price to Book Value : 5.927 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.864 |
| August 20, 2026 | 5.558 |
| August 19, 2026 | 6.144 |
| August 18, 2026 | 6.170 |
| August 17, 2026 | 5.966 |
| August 14, 2026 | 5.915 |
| August 13, 2026 | 5.966 |
| August 12, 2026 | 5.991 |
| August 11, 2026 | 6.195 |
| August 10, 2026 | 6.118 |
| August 07, 2026 | 6.297 |
| August 06, 2026 | 6.017 |
| August 05, 2026 | 6.246 |
| August 04, 2026 | 6.348 |
| August 03, 2026 | 5.940 |
| July 31, 2026 | 5.889 |
| July 30, 2026 | 5.966 |
| July 29, 2026 | 5.915 |
| July 28, 2026 | 5.966 |
| July 27, 2026 | 5.685 |
| July 24, 2026 | 5.838 |
| July 23, 2026 | 5.864 |
| July 22, 2026 | 5.736 |
| July 21, 2026 | 6.068 |
| July 20, 2026 | 5.940 |
| Date | Value |
|---|---|
| July 17, 2026 | 6.093 |
| July 16, 2026 | 5.711 |
| July 15, 2026 | 5.609 |
| July 14, 2026 | 5.405 |
| July 13, 2026 | 5.532 |
| July 10, 2026 | 5.660 |
| July 09, 2026 | 5.736 |
| July 08, 2026 | 5.787 |
| July 07, 2026 | 6.042 |
| July 06, 2026 | 5.915 |
| July 02, 2026 | 5.915 |
| July 01, 2026 | 5.966 |
| June 30, 2026 | 6.118 |
| June 29, 2026 | 5.515 |
| June 26, 2026 | 5.327 |
| June 25, 2026 | 4.784 |
| June 24, 2026 | 4.638 |
| June 23, 2026 | 4.512 |
| June 22, 2026 | 4.492 |
| June 18, 2026 | 4.199 |
| June 17, 2026 | 4.262 |
| June 16, 2026 | 4.074 |
| June 15, 2026 | 4.095 |
| June 12, 2026 | 4.011 |
| June 11, 2026 | 3.948 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.340 |
| Pfizer Inc. | 1.872 |
| ANI Pharmaceuticals, Inc. | 2.856 |
| Corcept Therapeutics, Inc. | 18.84 |
| Veru, Inc. | 1.568 |
Price to Book Value Related Metrics
| PS Ratio | 21.93 |
| Price | 2.325 |
| Earnings Yield | -6.58% |
| Market Cap | 1.034B |